Patents by Inventor Patrick Wuthrich

Patrick Wuthrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIVIDABLE GALENICAL FORM ALLOWING MODIFIED RELEASE OF THE ACTIVE INGREDIENT
    Publication number: 20140221449
    Abstract: Dividable galenical form for the modified release of active ingredient, wherein the non-subdivided galenical form and a portion of said form obtained by subdivision have identical dissolution profiles.
    Type: Application
    Filed: March 12, 2014
    Publication date: August 7, 2014
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Gilles FONKNECHTEN, Patrick Genty, Jean-Manuel Pean, Patrick Wuthrich
  • DIVIDABLE GALENICAL FORM ALLOWING MODIFIED RELEASE OF THE ACTIVE INGREDIENT
    Publication number: 20130295176
    Abstract: Dividable galenical form for the modified release of active ingredient, wherein the non-subdivided galenical form and a portion of said form obtained by subdivision have identical dissolution profiles.
    Type: Application
    Filed: June 12, 2013
    Publication date: November 7, 2013
    Inventors: Gilles FONKNECHTEN, Patrick Genty, Jean-Manuel Pean, Patrick Wuthrich
  • ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF PERINDOPRIL
    Publication number: 20120076856
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of perindopril, characterised in that it comprises perindopril or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: December 5, 2011
    Publication date: March 29, 2012
    Applicant: LES LABORATOIRES SERVIER
    Inventors: PATRICK WUTHRICH, Herve ROLLAND, Marc JULIEN
  • Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
    Patent number: 7892575
    Abstract: The invention relates to a coated solid orodispersible pharmaceutical composition for the administration of agomelatine by the oral, oromucosal or sublingual route.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: February 22, 2011
    Assignee: Les Laboratoires Servier
    Inventors: Mark Julien, Jean-Manuel Pean, Francois Tharrault, Patrick Wuthrich
  • Orodispersible pharmaceutical composition of perindopril
    Publication number: 20100267799
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of perindopril, characterised in that it comprises perindopril or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: June 22, 2010
    Publication date: October 21, 2010
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Patrick Wuthrich, Herve Rolland, Marc Julien
  • Orodispersible pharmaceutical composition of ivabradine
    Publication number: 20100267693
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of ivabradine, characterised in that it comprises ivabradine or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: June 23, 2010
    Publication date: October 21, 2010
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Patrick Wuthrich, Hervé Rolland, Marc Julien
  • Orodispersible pharmaceutical composition of agomelatine
    Publication number: 20100260840
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of agomelatine, characterised in that it comprises agomelatine and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: June 22, 2010
    Publication date: October 14, 2010
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Patrick Wuthrich, Hervé Rolland, Marc Julien, François Tharrault
  • Dividable galenical form allowing modified release of the active ingredient
    Publication number: 20090238870
    Abstract: Dividable galenical form for the modified release of active ingredient, wherein the non-subdivided galenical form and a portion of said form obtained by subdivision have identical dissolution profiles. Medicaments.
    Type: Application
    Filed: August 22, 2008
    Publication date: September 24, 2009
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Gilles Fonknechten, Patrick Genty, Jean-Manuel Pean, Patrick Wuthrich
  • Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
    Publication number: 20070134331
    Abstract: The invention relates to a coated solid orodispersible pharmaceutical composition for the administration of agomelatine by the oral, oromucosal or sublingual route.
    Type: Application
    Filed: December 14, 2006
    Publication date: June 14, 2007
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Marc Julien, Francois Tharrault, Jean-Manuel Pean, Patrick Wuthrich
  • Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone
    Patent number: 7182960
    Abstract: The present invention relates to a pharmaceutical composition for administration by the nasal route of 17-?-oestradiol and norethisterone.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: February 27, 2007
    Assignee: Les Laboratoires Servier
    Inventors: Gilles Fonknechten, Patrick Wuthrich, Yannis Tsouderos, Claire Varin
  • Nasal pharmaceutical composition of piribedil
    Publication number: 20060204449
    Abstract: The present invention relates to a pharmaceutical composition for the administration, by the nasal route, of piribedil in solution or in powder form.
    Type: Application
    Filed: July 16, 2004
    Publication date: September 14, 2006
    Inventors: Herve Rolland, Patrick Wuthrich
  • Orodispersible pharmaceutical composition of an antithrombotic compound
    Publication number: 20060167100
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of an antithrombotic compound (compound A), characterised in that it comprises compound A or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: July 16, 2004
    Publication date: July 27, 2006
    Inventors: Patrick Wuthrich, Herve Rolland, Marc Julien
  • Microcapsules for the delayed, controlled release of perindopril
    Publication number: 20060165808
    Abstract: The present invention relates to A microcapsule composition allowing the delayed and controlled release of perindopril, or of a pharmaceutically acceptable salt thereof, for administration by the oral route.
    Type: Application
    Filed: June 24, 2003
    Publication date: July 27, 2006
    Inventors: Bruno Huet De Barochez, Patrick Wuthrich, Valerie Legrand, Catherine Castan, Remi Meyrueix
  • Orodispersible pharmaceutical composition of agomelatine
    Publication number: 20050131071
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of agomelatine, characterised in that it comprises agomelatine and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: January 22, 2003
    Publication date: June 16, 2005
    Inventors: Patrick Wuthrich, Herve Rolland, Marc Julien, Francois Tharrault
  • Orodispersible pharmaceutical composition comprising ivabradine
    Publication number: 20050106238
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of ivabradine, characterised in that it comprises ivabradine or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: January 22, 2003
    Publication date: May 19, 2005
    Inventors: Patrick Wuthrich, Herve Rolland, Marc Julien
  • Orodispersible pharmaceutical composition comprising perindopril
    Publication number: 20050106237
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of perindopril, characterised in that it comprises perindopril or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: January 22, 2003
    Publication date: May 19, 2005
    Inventors: Patrick Wuthrich, Herve Rolland, Marc Julien
  • Orally dispersible pharmaceutical piribedil composition
    Publication number: 20050085485
    Abstract: The invention relates to a solid orodispersible pharmaceutical composition of piribedil, characterised in that it comprises piribedil, or a pharmaceutically acceptable salt thereof, and granules consisting of co-dried lactose and starch.
    Type: Application
    Filed: January 21, 2003
    Publication date: April 21, 2005
    Inventors: Patrick Wuthrich, Herve Rolland, Marc Julien
  • Pharmaceutical compositions for nasal delivery of estradiol and norethisterone
    Publication number: 20040180856
    Abstract: The present invention relates to a pharmaceutical composition for administration by the nasal route of 17-&bgr;-oestradiol and norethisterone.
    Type: Application
    Filed: January 12, 2004
    Publication date: September 16, 2004
    Inventors: Gilles Fonknechten, Patrick Wuthrich, Yannis Tsouderos, Claire Varin
  • Thermoformable solid pharmaceutical composition for controlled release of perindopril
    Publication number: 20040115227
    Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and perindopril or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 26, 2003
    Publication date: June 17, 2004
    Inventors: Patrick Wuthrich, Herve Rolland, Gilles Briault, Gerald Pichon, Francois Tharrault
  • Core tablet for controlled release of gliclazide after oral administration
    Patent number: 6733782
    Abstract: The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the release being insensitive to variations in the pH of the dissolution medium.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: May 11, 2004
    Assignee: Les Laboratories Servier
    Inventors: Bruno Huet De Barochez, Patrick Wuthrich, Louis Martin